We Made a List and Checked It Twice: BioSpace (DHX)’s Naughty and Nice
Google Inc. (GOOG)'s Calico Snags SSF Space As it Ramps Up Hiring
Biotech Investors Bail After Gilead Sciences, Inc. (GILD) Drug Price Fight
Pfizer (PFE) Note to Doctors Backfires As Scorn Mounts
Conkwest Nabs $50 Million and Snags Biotech Billionaire as Co-Chairman of the Board
FDA Approves Novo Nordisk A/S (NVO)'s Weight Management Drug Saxenda
Actavis (ACT), Adamas Pharmaceuticals (ADMS) Win FDA Approval for Alzheimer's Drug Namzaric
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand
Vanda Pharmaceuticals, Inc. (VNDA) Leaps After Regaining Drug Rights From Novartis AG (NVS)
Juno Therapeutics (JUNO) CEO Pockets $100 Million in IPO; Largest Investor Makes $1 Billion
SSF's Cytokinetics, Inc. (CYTK) Snags $675 Million+ Deal With Astellas Pharma Inc. (ALPMY)
Amgen (AMGN) Sponsors Biotech Incubator in MA to Support Biotech Startups
FDA Grants Accelerated Approval for Bristol-Myers Squibb Company (BMY)'s Skin Cancer Drug Opdivo
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD)
Johnson & Johnson (JNJ) Bets $700 Million on MacroGenics, Inc. (MGNX)'s Blood Cancer Drug
Big Pharmas Like Johnson & Johnson (JNJ), Boehringer Ingelheim Corporation. Eli Lilly (LLY), and Roche (RHHBY) are Shedding Jobs in Korea
Eli Lilly (LLY) Must Sell Dog Heartworm Line to Buy Novartis AG (NVS)'s Animal Health Unit
See All News >
Juno Therapeutics (JUNO) CEO Pockets $100 Million in IPO; Largest Investor Makes $1 Billion
SSF's Cytokinetics, Inc. (CYTK) Snags $675 Million+ Deal With Astellas Pharma Inc. (ALPMY)
Amgen (AMGN) Sponsors Biotech Incubator in MA to Support Biotech Startups
FDA Grants Accelerated Approval for Bristol-Myers Squibb Company (BMY)'s Skin Cancer Drug Opdivo
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD)
Johnson & Johnson (JNJ) Bets $700 Million on MacroGenics, Inc. (MGNX)'s Blood Cancer Drug
Big Pharmas Like Johnson & Johnson (JNJ), Boehringer Ingelheim Corporation. Eli Lilly (LLY), and Roche (RHHBY) are Shedding Jobs in Korea
Eli Lilly (LLY) Must Sell Dog Heartworm Line to Buy Novartis AG (NVS)'s Animal Health Unit
Five Quick Takes on Stem Cells: CIRM, Sanford-Burnham Medical, BioWorld, StemCells (STEM), Cellular Dynamics
U.S. Justice Department Claims Omnicare, Inc. (OCR) Received Kickbacks From Abbott Laboratories (ABT)
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely
MA's Ariad Pharmaceuticals, Inc. (ARIA) Inks $75 Million+ Commercialization Deal In Asia
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development
Why Weight Training Is A Better Belly Fat Workout Than Running, Harvard School of Public Health Study
The Reason Why Google Inc. (GOOG) Isn’t A Health Company
Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Drug Price War Takes Pharma Back To The Future
Oragenics, Inc. (OGEN) Exploring Strategic Alternatives for OTC Probiotics Biz
See All News >
//-->